氨溴索辅助治疗老年社区获得性肺炎患者的临床疗效

Clinical efficacy of ambroxol in the treatment of 78 elderly patients with community-acquired pneumonia

目的:探讨采用氨溴索辅助治疗老年社区获得性肺炎患者的疗效。方法:收治老年社区获得性肺炎患者156例,随机平分两组。均接受常规内科治疗,观察组在此基础上采用氨溴索辅助治疗,对比分析两组患者的疗效。结果:观察组治疗后临床症状及体征消失时间少于对照组。观察组患者治疗总有效率94.9%,高于对照组患者的83.3%,差异均有统计学意义(P<0.05)。结论:氨溴索辅助治疗老年社区获得性肺炎疗效确切,可显著促进临床症状及体征的消退。

Objective:To explore the efficacy of ambroxol in the treatment of elderly patients with community-acquired pneumonia.Methods:156 elderly patients with community-acquired pneumonia were selected,they were randomly divided into the two groups equally,all patients received routine medical treatment,and the observation group was treated with ambroxol on the basis of this,and the curative effects of the two groups were compared and analyzed.Results:The clinical symptoms and signs disappeared time after treatment in the observation group were less than those in the control group.The total effective rate of the observation group was 94.9%,which was higher than that of the control group of 83.3%,the differences between the groups were statistically significant(P<0.05).Conclusion:Ambroxol is an effective adjuvant therapy for elderly community-acquired pneumonia,and can significantly promote the disappearance of clinical symptoms and signs.